Possible isozyme-specific effects of experimental malaria infection with Plasmodium berghei on cytochrome P450 activity in rat liver microsomes

J Pharm Pharmacol. 1994 May;46(5):352-5. doi: 10.1111/j.2042-7158.1994.tb03811.x.

Abstract

We have investigated the effect of experimental malaria infection on rat cytochrome P450-mediated drug metabolism using ethoxyresorufin and metoprolol as probe compounds. Malaria infection caused a significant reduction in total intrinsic clearance of ethoxyresorufin in both low and high parasitaemia malaria compared with control (control 18.7 +/- 7.2; low parasitaemia 10.5 +/- 4.1; high parasitaemia 4.3 +/- 1.4 mL min-1). However, clearance of metoprolol was unchanged in malaria infection compared with control (control 2.7 +/- 1.2; malaria 4.0 +/- 1.7 mL min-1). The change in clearance of ethoxyresorufin was the result of a decrease in Vmax, with no apparent change in Km. There was no change in either Vmax or Km of metoprolol. These results indicate a possible isozyme-selective effect of experimental malaria.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Cytochrome P-450 Enzyme System / metabolism*
  • Disease Models, Animal
  • Isoenzymes / metabolism*
  • Malaria / drug therapy
  • Malaria / enzymology*
  • Male
  • Metoprolol / metabolism
  • Metoprolol / therapeutic use
  • Microsomes, Liver / enzymology*
  • Oxazines / metabolism
  • Oxazines / therapeutic use
  • Plasmodium berghei*
  • Rats
  • Rats, Wistar

Substances

  • Isoenzymes
  • Oxazines
  • ethoxyresorufin
  • Cytochrome P-450 Enzyme System
  • Metoprolol